---
title: "LeMaitre Vascular: Q4 Earnings Insights"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276938873.md"
description: "LeMaitre Vascular (NASDAQ:LMAT) reported its Q4 earnings on February 25, 2026, beating estimates with an EPS of $0.68 compared to the expected $0.67. Revenue increased by $8.74 million year-over-year. In the previous quarter, the company also exceeded EPS estimates, resulting in a 1.43% share price increase the following day. Historical performance shows consistent earnings growth, with actual EPS and revenue figures surpassing estimates in several recent quarters."
datetime: "2026-02-25T21:14:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276938873.md)
  - [en](https://longbridge.com/en/news/276938873.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276938873.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/276938873.md) | [繁體中文](https://longbridge.com/zh-HK/news/276938873.md)


# LeMaitre Vascular: Q4 Earnings Insights

**LeMaitre Vascular** (NASDAQ:LMAT) announced its Q4 earnings on Wednesday, February 25, 2026 at 04:05 PM.

Here's a breakdown of the earnings report.

### Earnings

LeMaitre Vascular beat estimated earnings by 1.49%, reporting an EPS of $0.68 versus an estimate of $0.67.

Revenue was up $8.74 million from the same period last year.

### Analysis of Past Earnings

During the previous quarter, the company beat on EPS by $0.18, leading to a 1.43% increase share price change the next day.

Here's a look at LeMaitre Vascular's past performance:

**Quarter**

**Q3 2025**

**Q2 2025**

**Q1 2025**

**Q4 2024**

**EPS Estimate**

0.57

0.57

0.50

0.49

**EPS Actual**

0.75

0.60

0.48

0.49

**Revenue Estimate**

62.26M

62.57M

57.61M

55.99M

**Revenue Actual**

61.05M

64.23M

59.87M

55.72M

To track all earnings releases for LeMaitre Vascular visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [LeMaitre Vascular, Inc. (LMAT.US)](https://longbridge.com/en/quote/LMAT.US.md)

## Related News & Research

- [A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K](https://longbridge.com/en/news/280880388.md)
- [Exploring LeMaitre Vascular's Earnings Expectations](https://longbridge.com/en/news/276768611.md)
- [LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Rating of "Moderate Buy" by Brokerages](https://longbridge.com/en/news/275199312.md)
- [Nomadar Secures $2M in 2026 Revenue, More Than Doubling 2025 | NOMA Stock News](https://longbridge.com/en/news/281242113.md)
- [Caleres’ Licensing Risk: Partner Performance, Brand Dilution, and Revenue Disruption Challenges](https://longbridge.com/en/news/281674788.md)